Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001062993-25-012967

Chief Executive Officer gave up 32,933 shares (to pay taxes)

  • Chief Executive Officer acquired 36,132 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Chief Executive Officer 2025-07-15 Option exercise +36,132 $44.33 $1,601,732 75,136 D
Kelderman Kim Chief Executive Officer 2025-07-15 Shares withheld for taxes −32,933 $51.42 $1,693,415 42,203 D
Derivatives
Kelderman Kim Chief Executive Officer 2025-07-15 Option exercise · Stock Option (Right to Buy) −36,132 48,176 D
Loading xslF345X05/form4.xml…